Novel therapeutic use of viral inflammation modulatory...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 38/16 (2006.01) A61K 38/11 (2006.01)

Patent

CA 2374681

The present invention provides a method of blocking xenograft rejection in a patient in need of such treatment by administering to said patient a virally- encoded complement control protein, referred to as the inflammation modulatory protein (<i>IMP</i>). The present invention further provides pharmaceutical compositions for the prevention or treatment of xenograft rejection comprising the IMP protein, alone or in combination with other immunosuppressive agents.

L'invention concerne une technique permettant de bloquer le rejet d'une xénogreffe chez un patient nécessitant un tel traitement. Cette technique consiste à administrer à ce patient une protéine régulatrice d'un complément viralement codée, dénommée protéine modulatrice d'inflammation (IMP). L'invention concerne également des compositions pharmaceutiques comprenant la protéine modulatrice d'inflammation, seule ou en combinaison avec d'autres agents immunosuppresseurs, et utilisées pour prévenir ou traiter le rejet de xénogreffe,.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel therapeutic use of viral inflammation modulatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel therapeutic use of viral inflammation modulatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel therapeutic use of viral inflammation modulatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1838559

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.